Cargando…

SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia

BACKGROUND: We screened out several hypermethylated solute carrier (SLC) family genes in acute myeloid leukemia by reduced representation bisulfite sequencing. SLC22A3 encodes an organic cation transport protein, which is critical for drug transportation and cellular detoxification. SLC22A3 is signi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Yu, Xu, Zi-jun, Zhou, Jing-dong, Wen, Xiang-mei, Jin, Ye, Yuan, Qian, Xia, Pei-hui, Feng, Yuan, Yang, Lei, Lin, Jiang, Qian, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716704/ https://www.ncbi.nlm.nih.gov/pubmed/36461046 http://dx.doi.org/10.1186/s13148-022-01373-w

Ejemplares similares

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022)

SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2019)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
por: Wen, Xiang-mei, et al.
Publicado: (2021)

H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2018)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
por: Sun, Guo‐Kang, et al.
Publicado: (2019)

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia
por: Buelow, Daelynn R., et al.
Publicado: (2020)

ALOX5AP is a new prognostic indicator in acute myeloid leukemia
por: Chen, Xin-Yi, et al.
Publicado: (2023)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms
por: Zhang, Ting‐juan, et al.
Publicado: (2020)

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
por: Yang, Lan, et al.
Publicado: (2018)

Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
por: Guo, Hong, et al.
Publicado: (2017)

Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia
por: Wang, Wenjun, et al.
Publicado: (2022)

High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia
por: Xu, Zi‐jun, et al.
Publicado: (2022)

Methylation status of DDIT3 gene in Chronic Myeloid Leukemia
por: Wang, Ya-li, et al.
Publicado: (2010)

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020)

DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
por: Jian, Jimo, et al.
Publicado: (2023)

Expression and prognosis analysis of DNMT family in acute myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2020)

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
por: Wang, Shi-sen, et al.
Publicado: (2021)

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2022)

Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia
por: Chen, Si-Liang, et al.
Publicado: (2020)

A three-gene signature might predict prognosis in patients with acute myeloid leukemia
por: Zhu, Xin, et al.
Publicado: (2020)

Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
por: Zhou, Lei, et al.
Publicado: (2018)

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
por: Wu, De-long, et al.
Publicado: (2022)

Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Shi, Jin-long, et al.
Publicado: (2015)

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2019)

SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
por: Singh, Onkar, et al.
Publicado: (2012)

Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
por: Lee, Young Eun, et al.
Publicado: (2022)

Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
por: Cao, Yang, et al.
Publicado: (2022)

High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2017)

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2019)

EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia
por: Chu, Ming‐qiang, et al.
Publicado: (2019)

Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia
por: Zhang, Ling‐yi, et al.
Publicado: (2021)

Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
por: Li, Xi-xi, et al.
Publicado: (2019)

Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation
por: Gu, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eqiod3ike7ho37chcv2lqrff6j